A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors
Clinical trial NCT04434092 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04434092
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-08
- Primary completion
- 2022-11-16
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.